Citation: | LIU Caiyun, SHI Jianhong, ZHOU Jinsa, ZHAO Mingzhi, WANG Bing, CUI Naipeng, CHEN Baoping. Mechanism of TNFα Regulating KLF4 Expression in Breast Cancer Cells SK-BR-3[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 117-120. DOI: 10.3971/j.issn.1000-8578.2015.02.004 |
[1] |
Scully OJ, Bay BH, Yip G, et al. Breast cancer metastasis[J]. Cancer Genomics Proteomics, 2012, 9(5): 311-20.
|
[2] |
Soria G, Ofri-Shahak M, Haas I, et al. Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition[J]. BMC Cancer, 2011, 11: 130.
|
[3] |
Shi JH, Zheng B, Chen S, et al. Retinoic acid receptor α mediates all-trans-retinoic acid-induced Klf4 gene expression by regulating Klf4 promoter activity in vascular smooth muscle cells[J]. J Biol Chem, 2012, 287(14):10799-811.
|
[4] |
Bieker JJ. Krüppel-like factors: three finger in many pies[J]. J Biol Chem,2001,276(37): 34355-8.
|
[5] |
Nagata T. The influence of iPS-inducing factors NANOG and KLF4 in the prognosis of patients with breast cancer[J]. J Clin Oncol, 2011, 29 (suppl 27): abstr 230.
|
[6] |
Ohnishi S, Ohnami S, Laub F, et al. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer[J]. Biochem Biophys Res Commun, 2003, 308(2): 251-6.
|
[7] |
Zhao W, Hisamuddin IM, Nandan MO, et al. Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer[J]. Oncogene, 2004, 23(2):395-402.
|
[8] |
Tetreault MP, Wang ML, Yang Y, et al. Klf4 overexpression a c t i v a t e s e p i t h e l i a l c y t o k i n e s a n d i n f l amma t i o n - mediated esophageal squamous cell cancer in mice[J]. Gastroenterology,2010, 139(6): 2124-34.
|
[9] |
Wang J, Place RF, Huang V, et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration[J]. Cancer Res, 2010,70(24):10182-91.
|
[10] |
Cui NP, Yan WT, Liu CY, et al. Expressions of KLF4 and KLF5 in breast invasive ductal carcinoma and their clinical significance[J]. Lin Chuang Zhong Liu Xue Zai Zhi,2013,18(12):1087-90.[崔乃 鹏, 闫伟涛, 刘彩云, 等. KLF4和KLF5在乳腺浸润性导管癌中 的表达及意义[J]. 临床肿瘤学杂志, 2013, 18(12): 1087-90.]
|
[11] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
[12] |
He J, Chen WQ. Chinese cancer registry annual report[M]. Beijing: Military Medical Science Press, 2012,14-27.[赫捷, 陈 万青.2012中国肿瘤登记年报[M]. 北京: 军事医学科学出版社, 20 12: 14-27.]
|
[13] |
Zheng B, Han M, Wen JK. Role of Krüppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells[J]. IUBMB Life, 2010, 62(2): 132-9.
|
[14] |
Yu F, Li J, Chen H, et al. Krüppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion [J]. Oncogene, 2011, 30(18): 2161-72.
|
[15] |
Akaogi K, Nakajima Y, Ito I, et al. KLF4 suppresses estrogendependent breast cancer growth by inhibiting the transcriptional activity of ERalpha[J]. Oncogene, 2009, 28(32): 2894-902.
|
[16] |
Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer[J]. Clin Cancer Res, 2004, 10(8): 2709-19.
|
[1] | MA Yunlong, ZHU Bin, LIU Xiaoguang. Research Advances of ASPP in Regulating Apoptosis of Tumor Cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 409-412. DOI: 10.3971/j.issn.1000-8578.2016.05.019 |
[2] | TU Yunhua, LI Ming’e, KANG Yingqian, RONG Dongyun, ZHOU Ying, XUE Yuecui, YE Zhenyuan, ZAN Zhenyuan, CAO Yu. Effect of Terpinen-4-ol on Proliferation and Apoptosis of Human Multiple Myeloma Cells U266[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 355-359. DOI: 10.3971/j.issn.1000-8578.2016.05.008 |
[3] | GUO Junfu, WANG Yanjie, MIAO Lanying, CONG Peiwei. Effect of Silencing Toll-like Receptor 4 Expression on Cell Cycle and Apoptosis of Human Lung Adenocarcinoma Cells A549[J]. Cancer Research on Prevention and Treatment, 2015, 42(03): 225-228. DOI: 10.3971/j.issn.1000-8578.2015.03.003 |
[4] | ZHANG Minkang, GUO Hao, TIAN Qingzhong, LI Jin. Embelin Synergistically Enhances TRAIL-induced Apoptotic Death in Breast Cancer Cell Line MDA-MB-231[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1195-1199. DOI: 10.3971/j.issn.1000-8578.2014.11.008 |
[5] | ZHANG Xiao-chun, WEI Xue-li, CHEN Cheng. Sensitivity of T-cell Acute Lymphoblastic Leukemia to TRAIL Induced Apoptosis[J]. Cancer Research on Prevention and Treatment, 2011, 38(12): 1385-1388. DOI: 10.3971/j.issn.1000-8578.2011.12.011 |
[6] | LU Hong, FAN Qing-xia, WANG Rui-lin. Apoptosis in Paclitaxel Resistant Cell Line Ec9706/P-1 of Human Esophageal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1356-1359. DOI: 10.3971/j.issn.1000-8578.2010.12.006 |
[7] | WANG Yong-qian, LU Jian-rong. N-4-Hydroxyphenyl Retinoid-Induced Apoptosis is Associated with Down-Regulation of Bcl-xL in Human Medulloblastoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(01): 5-8. DOI: 10.3971/j.issn.1000-8578.2010.01.002 |
[8] | LIU Yan, YANG Wan-hua, MA Xiang-yi, CHEN Rui, WANG Rui, LU Yun-ping, MA Ding, WANG Shi-xuan. The Effect of Vascular Endothelial Growth Factor Receptor-3 on the Apoptosis of Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 659-661. DOI: 10.3971/j.issn.1000-8578.1319 |
[9] | ZHONG Li-ping, CHENG Ke-lu, YANG Yu-ming, LI De-xiang. Study of The Relationship of Cellular Proliferation and Apoptosis in Thyroid Neoplasms[J]. Cancer Research on Prevention and Treatment, 2005, 32(11): 710-712. DOI: 10.3971/j.issn.1000-8578.2222 |
[10] | HOU Gan, HUANG Di-nan, ZHU Qi-feng. Effect of Cell Cycle in Hela Cells to Apoptos is Induced by Tumor Necrosis Factor[J]. Cancer Research on Prevention and Treatment, 2001, 28(05): 336-338. DOI: 10.3971/j.issn.1000-8578.1363 |